These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7902662)

  • 1. Inhibition of topoisomerases in African trypanosomes.
    Shapiro TA
    Acta Trop; 1993 Sep; 54(3-4):251-60. PubMed ID: 7902662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs.
    Shapiro TA; Englund PT
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):950-4. PubMed ID: 2153980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
    Tang SC; Shapiro TA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):620-6. PubMed ID: 20008775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs affecting trypanosome topoisomerases.
    Shapiro TA
    Adv Pharmacol; 1994; 29B():187-200. PubMed ID: 8996608
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility of dyskinetoplastic Trypanosoma evansi and T. equiperdum to isometamidium chloride.
    Kaminsky R; Schmid C; Lun ZR
    Parasitol Res; 1997; 83(8):816-8. PubMed ID: 9342750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suramin: Effectiveness of analogues reveals structural features that are important for the potent trypanocidal activity of the drug.
    Steverding D; Tinson RAJ; Piras M; Wren SP; Rushworth SA; Searcey M; Troeberg L
    Exp Parasitol; 2024 May; 260():108744. PubMed ID: 38513971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma brucei evansi: dyskinetoplasia and loss of infectivity after long-term in vitro cultivation.
    Zweygarth E; Kaminsky R; Webster P
    Acta Trop; 1990 Dec; 48(2):95-9. PubMed ID: 1980574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
    Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
    J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin.
    Morty RE; Troeberg L; Pike RN; Jones R; Nickel P; Lonsdale-Eccles JD; Coetzer TH
    FEBS Lett; 1998 Aug; 433(3):251-6. PubMed ID: 9744805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
    Zhang ZQ; Giroud C; Baltz T
    Acta Trop; 1991 Dec; 50(2):101-10. PubMed ID: 1685865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.
    Cavalcanti DP; Fragoso SP; Goldenberg S; de Souza W; Motta MC
    Parasitol Res; 2004 Dec; 94(6):439-48. PubMed ID: 15517387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles.
    Shapiro TA; Showalter AF
    Mol Cell Biol; 1994 Sep; 14(9):5891-7. PubMed ID: 8065322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in resistance to isometamidium chloride and diminazene aceturate by clones derived from a stock of Trypanosoma congolense.
    Peregrine AS; Knowles G; Ibitayo AI; Scott JR; Moloo SK; Murphy NB
    Parasitology; 1991 Feb; 102 Pt 1():93-100. PubMed ID: 2038504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
    Hannaert V
    Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
    Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
    Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of verapamil alone and in combination with trypanocides on multidrug-resistant Trypanosoma brucei brucei.
    Kaminsky R; Zweygarth E
    Acta Trop; 1991 Aug; 49(3):215-25. PubMed ID: 1685302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
    Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
    Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity to trypanocidal drugs of Trypanosoma vivax isolated in Kenya and Somalia.
    Schönefeld A; Röttcher D; Moloo SK
    Trop Med Parasitol; 1987 Sep; 38(3):177-80. PubMed ID: 3432953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of existing drugs for animal trypanosomiasis.
    Kinabo LD
    Acta Trop; 1993 Sep; 54(3-4):169-83. PubMed ID: 7902656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ATP-Based Luciferase Viability Assay for Animal African Trypanosomes Using a 96-Well Plate.
    Suganuma K; Molefe NI; Inoue N
    Methods Mol Biol; 2017; 1601():89-95. PubMed ID: 28470520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.